A Rivero-Juárez Selected Research

Chronic Hepatitis C

5/2017

Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Rivero-Juárez Research Topics

Disease

6	Fibrosis (Cirrhosis) 12/2020 - 09/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2017 - 12/2017
2	Infections 05/2017 - 03/2015
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021
1	Reinfection 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2020
1	Chronic Hepatitis C 05/2017
1	HIV Infections (HIV Infection) 10/2015
1	Hemorrhage 09/2015
1	Thrombocytopenia (Thrombopenia) 09/2015
1	Hepatitis C 01/2014

Drug/Important Bio-Agent (IBA)

2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2015
2	Antiviral Agents (Antivirals)IBA 12/2020 - 05/2017
2	HLA-B18 AntigenIBA 12/2017 - 12/2017
2	InterferonsIBA 10/2015 - 09/2015
2	Ribavirin (Virazole)FDA LinkGeneric 10/2015 - 09/2015
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	LipopolysaccharidesIBA 01/2018
1	16S Ribosomal RNAIBA 01/2018
1	Ribosomal DNA (rDNA)IBA 01/2018
1	Lipopolysaccharide ReceptorsIBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 12/2017
1	Complement Receptors (Complement Receptor)IBA 03/2015
1	Complement System Proteins (Complement)IBA 03/2015
1	P-2 (P 2)IBA 03/2015
1	Complement 3d Receptors (Complement Receptor 2)IBA 03/2015
1	LDL Receptors (LDL Receptor)IBA 01/2014

Therapy/Procedure

5	Therapeutics 12/2020 - 09/2015
1	Liver Transplantation 12/2020